205 related articles for article (PubMed ID: 15091230)
21. Ototoxicity: therapeutic opportunities.
Rybak LP; Whitworth CA
Drug Discov Today; 2005 Oct; 10(19):1313-21. PubMed ID: 16214676
[TBL] [Abstract][Full Text] [Related]
22. Dose-dependent inner ear changes after i.v. administration of cisplatin.
Laurell G; Bagger-Sjöbäck D
J Otolaryngol; 1991 Jun; 20(3):158-67. PubMed ID: 1870163
[TBL] [Abstract][Full Text] [Related]
23. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
[TBL] [Abstract][Full Text] [Related]
24. [Morphological and functional correlations of the protective action of coenzyme A in cisplatin ototoxicity (II)].
Ayala Martínez L; Fernández F; Crespo PV; Campos A; Ciges M
Acta Otorrinolaringol Esp; 1997 May; 48(4):265-7. PubMed ID: 9376135
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.
Dehne N; Lautermann J; Petrat F; Rauen U; de Groot H
Toxicol Appl Pharmacol; 2001 Jul; 174(1):27-34. PubMed ID: 11437646
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
[TBL] [Abstract][Full Text] [Related]
27. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
[TBL] [Abstract][Full Text] [Related]
28. Functional and morphological effects of styrene on the auditory system of the rat.
Mäkitie A; Pirvola U; Pyykkö I; Sakakibara H; Riihimäki V; Ylikoski J
Arch Toxicol; 2002 Feb; 76(1):40-7. PubMed ID: 11875623
[TBL] [Abstract][Full Text] [Related]
29. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
30. [Morphological and functional correlations of the protective action of pantothenic acid in cisplatin ototoxicity (I)].
Martínez Martínez MJ; Fernández Cervilla F; Crespo VP; Giges M; Campos A
Acta Otorrinolaringol Esp; 1997 May; 48(4):261-4. PubMed ID: 9376134
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
[TBL] [Abstract][Full Text] [Related]
32. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.
Wolters FL; Klis SF; Hamers FP; de Groot JC; Smoorenburg GF
Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750
[TBL] [Abstract][Full Text] [Related]
33. Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures.
Corbacella E; Lanzoni I; Ding D; Previati M; Salvi R
Hear Res; 2004 Nov; 197(1-2):11-8. PubMed ID: 15504599
[TBL] [Abstract][Full Text] [Related]
34. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
35. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
O'Leary SJ; Klis SF
Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity.
Roldán-Fidalgo A; Martín Saldaña S; Trinidad A; Olmedilla-Alonso B; Rodríguez-Valiente A; García-Berrocal JR; Ramírez-Camacho R
Exp Toxicol Pathol; 2016 Apr; 68(4):197-204. PubMed ID: 26850526
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
38. HSP-70 as a nonspecific early marker in cisplatin ototoxicity.
Ramírez-Camacho R; Citores MJ; Trinidad A; Verdaguer JM; García-Berrocal JR; Marero AM; Puente A; González-García JA; Vargas JA
Acta Otolaryngol; 2007 Jun; 127(6):564-7. PubMed ID: 17503223
[TBL] [Abstract][Full Text] [Related]
39. A low-dose regimen of cisplatin before high-dose cisplatin potentiates ototoxicity.
Harrison RT; DeBacker JR; Bielefeld EC
Laryngoscope; 2015 Feb; 125(2):E78-83. PubMed ID: 25267530
[TBL] [Abstract][Full Text] [Related]
40. Aminoguanidine prevents ototoxicity induced by cisplatin in rats.
Iraz M; Kalcioglu MT; Kizilay A; Karatas E
Ann Clin Lab Sci; 2005; 35(3):329-35. PubMed ID: 16081592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
